Inhibition of blood group antibodies by soluble substances
By: K.M. Byrne, C.M.C. Mercado, T.N. Nnabue, T.D. Paige and W.A. Flegel
Paid access
|Feb 2020Authors
K.M. Byrne
National Institutes of Health (NIH) Clinical Center, Department of Transfusion Medicine, Bethesda, US
C.M.C. Mercado
American Red Cross, Pomona, US
T.N. Nnabue
Transfusion Medicine, Walter Reed National Military Medical Center, Bethesda, US
T.D. Paige
National Institutes of Health (NIH) Clinical Center, Department of Transfusion Medicine, Bethesda, US
W.A. Flegel
National Institutes of Health (NIH) Clinical Center, Department of Transfusion Medicine, Bethesda, US
DOI: https://doi.org/10.21307/immunohematology-2020-008 | Journal eISSN: 1930-3955 | Journal ISSN: 0894-203X
Language: English
Page range: 19 - 22
Published on: Feb 15, 2020
Published by: American National Red Cross
In partnership with: Paradigm Publishing Services
Publication frequency: 4 issues per year
Keywords:
Related subjects:
© 2020 K.M. Byrne, C.M.C. Mercado, T.N. Nnabue, T.D. Paige, W.A. Flegel, published by American National Red Cross
This work is licensed under the Creative Commons License.